NYSE:PRGOPharmaceuticals
Perrigo Cost Reset Program Faces Impairment Hit And Transition Year
Perrigo (NYSE:PRGO) has announced a new operational enhancement program after reporting significant progress on its Three-S transformation approach.
The company highlighted a tripling in the value of its innovation pipeline and more than US$100 million in new distribution wins.
Perrigo also reported a major net loss for the fourth quarter and full year, linked in part to an asset impairment charge.
Management described 2026 as a transition year, citing manufacturing under-absorption, and is...